Serum Cystatin C and Cardiac Rehabilitation E15C ardiac rehabilitation (CR), 1 including an appropriate level of exercise training, has been proved to improve coronary risk factors 2 and exercise capacity 3 in patients with chronic kidney disease (CKD). However, the effects of CR on renal function in patients with CKD remain controversial. It is important to evaluate the effect on renal function in CKD patients with cardiovascular disease (CVD) because a previous study showed that CKD patients with higher renal dysfunction severity had higher risks of death, CVD events, and hospitalization than those with lower renal dysfunction. 4 Some previous studies have suggested the potential benefit of exercise training on renal function. 3,5,6 However, the results are not definitive and their findings may be affected by the use of serum creatinine to evaluate renal function, 7 as resistance training can lead to elevated serum creatinine level. [8][9][10] Recent studies have recommended the use of serum concentration of cystatin C (Scys) to evaluate renal function in patients with CKD. Since Scys is not affected by muscle mass, Scys can be an optimal marker of renal function in patients who undergo CR. [11][12][13] Recently, some studies using estimated glomerular filtration rate using the serum concentration of cystatin C (eGFRcys) evaluated the effect of CR on renal function of CVD patients, and they showed a favorable effect of CR on renal function. 14,15 However, for patients with CVD, little is known about whether CR improves renal function, as measured by Scys, particularly in patients with severe CKD. A previous small observational study using Scys (n = 41) demonstrated that high physical activity may suppress renal function decline in patients after acute myocardial infarction. 16 Another pilot randomized controlled trial reported a 1-yr exercise intervention on the progression of renal function was inconclusive. 17 Even assuming the potential benefit of CR on renal function, it remains unclear whether CR has a beneficial effect on patients with severe renal dysfunction (eg, patients who are eligible for dialysis), and whether the effect differs across the baseline CKD severity. We hypothesized that CR would have a beneficial effect on glomerular filtration rate (GFR) measured by Scys in patients with CKD, even in those with severe renal dysfunction.To address the knowledge gap in the literature, we aimed to evaluate the effect of CR on renal function in patients with CKD, particularly in those with severe CKD. In addition, we investigated the association of the baseline renal function with the degree of CR effects on the renal function using Scys.
METHODSThis was a retrospective cohort study using data of patients who were admitted to the Tokai University Hachioji Hospital